Alterity Therapeutics (ATHE) EBITDA Margin Growth (1y) (2017 - 2019)
Alterity Therapeutics (ATHE) EBITDA Margin Growth (1y) (2017 - 2019) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.90 Bn | 131.05 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 86.10 Bn | 78.11 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 65.56 Bn | 60.37 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 55.82 Bn | 50.68 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 42.14 Bn | 37.04 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.67 Bn | 28.36 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 27.74 Bn | 9.35 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.53 Bn | 26.37 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - | -1,651.00 |
| 10 | Alterity Therapeutics | 48.08 Mn | 15.78 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | -8,137.00 |
| Dec 31, 2018 | -340,079.00 |
| Dec 31, 2017 | 338,683.00 |